Covid-19 Treatment Developer Humanigen Files for Bankruptcy

null By Becky YerakJan. 4, 2024 4:32 pm ET|WSJ ProHumanigen said an entity affiliated with its chief executive is interested in buying the company out of bankruptcy. Photo: John Nacion/Zuma PressPharmaceutical developer Humanigen has filed for bankruptcy, attributing its financial problems largely to the U.S. Food and Drug Administration’s rejection of its Covid-19 drug in 2021.The Burlingame, Calif.-based company, once controlled by convicted pharma fraudster Martin Shkreli, sought protection from creditors Wednesday with unsecured debts of $44.1 million, while listing assets of $521,000. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

A person who loves writing, loves novels, and loves life.Seeking objective truth, hoping for world peace, and wishing for a world without wars.

Opinion Jan 5, 2024 Add to Reading List

Covid-19 Treatment Developer Humanigen Files for Bankruptcy

null

By Becky Yerak

Jan. 4, 2024 4:32 pm ET|WSJ Pro

Humanigen said an entity affiliated with its chief executive is interested in buying the company out of bankruptcy. Photo: John Nacion/Zuma Press

Pharmaceutical developer Humanigen has filed for bankruptcy, attributing its financial problems largely to the U.S. Food and Drug Administration’s rejection of its Covid-19 drug in 2021.

The Burlingame, Calif.-based company, once controlled by convicted pharma fraudster Martin Shkreli, sought protection from creditors Wednesday with unsecured debts of $44.1 million, while listing assets of $521,000.